← Browse by Condition
Medical Condition
recurrent ovary cancer
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
NCT06964009 Phase 1
Recruiting
DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer
Enrollment
30 pts
Location
United States
Sponsor
Elizabeth Stover, MD, PhD
NCT06321484 Phase 1
Recruiting
Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
Enrollment
18 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute